106
Participants
Start Date
November 29, 2021
Primary Completion Date
April 4, 2023
Study Completion Date
April 4, 2023
Opicapone
50 mg hard capsules. Oral administration, once-daily at bedtime, at least 1 hour before or after L-DOPA/carbidopa or benserazide (L-DOPA/DDCI).
L-DOPA/DDCI
L-DOPA/carbidopa or benserazide (L-DOPA/DDCI), 100/25 mg, oral administration
Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin
Praxis Dr. med. Kirsten Hahn, Berlin
Complejo Hospitalario Universitario A Coruña, A Coruña
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan
Hospital Ruber Internacional, Madrid
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Complejo Hospitalario Universitario de Orense, Ourense
Azienda Ospedaliero Universitaria Pisana, Pisa
Parkinson-Klinik Ortenau GmbH&Co KG, Wolfach
Universitaetsklinikum Freiburg, Freiburg im Breisgau
"Azienda Ospedaliera Universitaria- Università degli Studi della Campania Luigi Vanvitelli", Napoli
Klinik Haag i. OB, Haag in Oberbayern
Universitaetsklinikum Wuerzburg, Würzburg
Praxis Dr. Oehlwein, Gera
Asklepios Fachklinikum Stadtroda, Stadtroda
Azienda Ospedaliera Santa Maria di Terni, Terni
Hospital Beatriz Ângelo, Loures
CNS-Campus Neurologico Senior, Torres Vedras
Hospital General Universitario de Elche, Elche
Hospital de Sant Joan Despi Moises Broggi, Sant Joan Despí
Hospital Universitari Vall d'Hebron, Barcelona
Royal Devon and Exeter Hospital (Wonford), Exeter
University Hospitals Plymouth, Plymouth
King's College Hospital, London
Newcastle University- Clinical Ageing Research Unit, Newcastle upon Tyne
Bial - Portela C S.A.
INDUSTRY